IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Por um escritor misterioso

Descrição

IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition - ScienceDirect
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Multivalent antibodies show high potency against SARS-CoV-2 in new study
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency: Cell
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Frontiers Nanobodies: COVID-19 and Future Perspectives
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses - ScienceDirect
de por adulto (o preço varia de acordo com o tamanho do grupo)